Radioligand Therapy Market to Grow from USD 2.98 Billion in 2025 to USD 15.85 Billion by 2035, at a CAGR of 18.2% – SNS Insider

U.S. Radioligand Therapy Market to Reach USD 10.68 Billion and Europe USD 1.79 Billion by 2035 as PSMA-Targeted Therapies, Alpha-Emitter Innovation, and Expanding Isotope Production Drive Demand.

U.S. Radioligand Therapy Market to Reach USD 10.68 Billion and Europe USD 1.79 Billion by 2035 as PSMA-Targeted Therapies, Alpha-Emitter Innovation, and Expanding Isotope Production Drive Demand.